SCHEMBL1718796

SCHEMBL1718796

Nc1cc(O)cc([N+](=O)[O-])c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
TSHR P16473 2/20 0.50
GPR35 Q9HC97 2/20 0.50
ALOX15 P16050 2/20 0.50
NPC1 O15118 1/20 0.47
GAA P10253 1/20 0.47
THRB P10828 1/20 0.47
MEN1 O00255 2/20 0.47
HTT P42858 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP19A1 P11511 1/20 0.44
POLB P06746 1/20 0.44
KDM4E B2RXH2 1/20 0.44
TTR P02766 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3913976 1.00 ALDH1A1 (0.50) ALDH1A1TSHRGPR35ALOX15NPC1
SCHEMBL539064 0.84 ALDH1A1 (0.60) ALDH1A1TSHRGPR35ALOX15NPC1
SCHEMBL69389 0.84 ALDH1A1 (0.60) ALDH1A1TSHRGPR35ALOX15MEN1
SCHEMBL593064 0.84 CYP19A1 (0.62) ALDH1A1TSHRGPR35ALOX15MEN1
SCHEMBL65293 0.84 CYP19A1 (0.62) ALDH1A1TSHRGPR35ALOX15NPC1
SCHEMBL9265700 0.84 ALDH1A1 (0.60) ALDH1A1TSHRGPR35ALOX15MEN1
SCHEMBL30387741 0.81 CYP19A1 (0.59) ALDH1A1TSHRGPR35ALOX15MEN1
SCHEMBL29381787 0.81 CYP19A1 (0.59) ALDH1A1TSHRGPR35ALOX15MEN1
Water SCHEMBL28180935 0.81 CYP19A1 (0.59) ALDH1A1TSHRGPR35ALOX15MEN1
Phenol SCHEMBL27520174 0.80 ALDH1A1 (0.53) ALDH1A1TSHRGPR35ALOX15NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP claimed
WO-2008021250-A2 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING BCL-2 FAMILY MEMBER PROTEINS FRED HUTCHINSON CANCER RESEARCH CENTER (US) 2008-02-21 WO disclosed
US-7098335-B2 Pyrazolopyrimidine compositions ICAGEN, INC. (US) 2006-08-29 US disclosed
US-6833371-B2 Contacting cell with a sodium channel-inhibiting amount of a compound comprising a pyrazolopyrimidine moiety for decreasing ion flow through a voltage-dependent sodium channel in a cell ICAGEN, INC. 2004-12-21 US disclosed